
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2285-2293.DOI: 10.12114/j.issn.1007-9572.2024.0222
Special Issue: 共病最新文章合辑; 心血管最新文章合辑; 肥胖/减重最新文章合辑
• Article·Cardiovascular and Metabolic Comorbidities Section • Previous Articles Next Articles
Received:2024-06-10
Revised:2024-10-10
Published:2025-06-20
Online:2025-04-25
Contact:
WANG Weiqiang
通讯作者:
王为强
作者简介:作者贡献:
潘姚佳、傅方琳、韩正、孙梦、顾怀聪负责试验的实施、实施数据的收集;潘姚佳、顾怀聪负责整理数据;潘姚佳负责分析数据、论文撰写;王为强负责试验研究规划及监督、论文质量审校及指导、经费支持,对论文负责;潘姚佳、傅方琳负责论文润色及修改。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0222
| 特征 | 男性 | 女性 | 总人群 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非共病(n=22 281) | 共病(n=4 445) | χ2(Z)值 | P值 | 非共病(n=38 170) | 共病(n=5 916) | χ2(Z)值 | P值 | 非共病(n=60 451) | 共病(n=10 361) | χ2(Z)值 | P值 | |
| 在婚[例(%)] | 20 927(93.9) | 4 164(93.7) | 0.387 | 0.534 | 35 243(92.3) | 5 413(91.5) | 4.966 | 0.026 | 56 170(92.9) | 9 577(92.4) | 3.134 | 0.077 |
| 高中及以上学历[例(%)] | 3 494(15.7) | 984(22.1) | 110.727 | <0.001 | 3 044(8.0) | 436(7.4) | 2.579 | 0.108 | 6 538(10.8) | 1 420(13.7) | 74.051 | <0.001 |
| 农民[例(%)] | 13 263(59.5) | 2 257(50.8) | 116.521 | <0.001 | 24 125(63.2) | 3 824(64.6) | 4.540 | 0.033 | 37 388(61.8) | 6 081(58.7) | 37.195 | <0.001 |
| 吸烟[例(%)] | 10 533(47.3) | 2 127(47.9) | 0.497 | 0.481 | 521(1.4) | 111(1.9) | 9.477 | 0.002 | 11 054(18.3) | 2 238(21.6) | 63.723 | <0.001 |
| 饮酒[例(%)] | 7 268(32.6) | 1 549(34.8) | 8.324 | 0.004 | 1 307(3.4) | 166(2.8) | 6.061 | 0.014 | 8 575(14.2) | 1 715(16.6) | 39.915 | <0.001 |
| 年龄[M(QR),岁] | 54.0(10.0) | 56.0(10.0) | 12.403a | <0.001 | 53.0(8.0) | 56.0(8.0) | 31.874a | <0.001 | 54.0(9.0) | 56.0(9.0) | 32.620a | <0.001 |
| FBG[M(QR),mmol/L] | 5.70(1.14) | 6.40(2.30) | 38.514a | <0.001 | 5.60(1.20) | 6.40(2.40) | 46.012a | <0.001 | 5.60(1.20) | 6.40(2.40) | 60.344a | <0.001 |
| TG[M(QR),mmol/L] | 1.26(0.83) | 2.06(1.53) | 46.065a | <0.001 | 1.34(0.80) | 2.25(1.38) | 59.592a | <0.001 | 1.31(0.82) | 2.17(1.45) | 74.600a | <0.001 |
| TyG[M(QR)] | 8.67(0.70) | 9.29(0.81) | 55.643a | <0.001 | 8.72(0.66) | 9.34(0.72) | 71.337a | <0.001 | 8.70(0.67) | 9.32(0.76) | 90.000a | <0.001 |
| BMI[M(QR),kg/m2] | 24.30(3.73) | 26.17(4.00) | 35.242a | <0.001 | 24.29(4.14) | 25.92(4.59) | 33.903a | <0.001 | 24.29(3.97) | 26.03(4.38) | 48.446a | <0.001 |
| TC[M(QR),mmol/L] | 4.28(1.19) | 4.37(1.56) | 7.044a | <0.001 | 4.63(1.26) | 5.06(1.90) | 26.988a | <0.001 | 4.49(1.25) | 4.77(1.79) | 22.602a | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.36(0.50) | 1.10(0.41) | 41.533a | <0.001 | 1.50(0.52) | 1.33(0.52) | 30.568a | <0.001 | 1.45(0.52) | 1.23(0.51) | 51.037a | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.27(1.05) | 2.24(1.29) | 1.053a | 0.293 | 2.46(1.09) | 2.66(1.61) | 17.042a | <0.001 | 2.39(1.09) | 2.47(1.49) | 12.104a | <0.001 |
| 肥胖类型[例(%)] | 1 190.460 | <0.001 | 1 129.644 | <0.001 | 2 249.081 | <0.001 | ||||||
| 非肥胖 | 9 322(41.8) | 855(19.2) | 15 426(40.4) | 1 308(22.1) | 24 748(40.9) | 2 163(20.9) | ||||||
| 外周型肥胖 | 5 735(25.7) | 1 033(23.2) | 7 898(20.7) | 1 018(17.2) | 13 633(22.6) | 2 051(19.8) | ||||||
| 中心型肥胖 | 664(3.0) | 142(3.2) | 1 892(5.0) | 307(5.2) | 2 556(4.2) | 449(4.3) | ||||||
| 复合型肥胖 | 6 560(29.4) | 2 415(54.3) | 12 954(33.9) | 3 283(55.5) | 19 514(32.3) | 5 698(55.0) | ||||||
Table 1 General information and prevalence of CMM in different populations
| 特征 | 男性 | 女性 | 总人群 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 非共病(n=22 281) | 共病(n=4 445) | χ2(Z)值 | P值 | 非共病(n=38 170) | 共病(n=5 916) | χ2(Z)值 | P值 | 非共病(n=60 451) | 共病(n=10 361) | χ2(Z)值 | P值 | |
| 在婚[例(%)] | 20 927(93.9) | 4 164(93.7) | 0.387 | 0.534 | 35 243(92.3) | 5 413(91.5) | 4.966 | 0.026 | 56 170(92.9) | 9 577(92.4) | 3.134 | 0.077 |
| 高中及以上学历[例(%)] | 3 494(15.7) | 984(22.1) | 110.727 | <0.001 | 3 044(8.0) | 436(7.4) | 2.579 | 0.108 | 6 538(10.8) | 1 420(13.7) | 74.051 | <0.001 |
| 农民[例(%)] | 13 263(59.5) | 2 257(50.8) | 116.521 | <0.001 | 24 125(63.2) | 3 824(64.6) | 4.540 | 0.033 | 37 388(61.8) | 6 081(58.7) | 37.195 | <0.001 |
| 吸烟[例(%)] | 10 533(47.3) | 2 127(47.9) | 0.497 | 0.481 | 521(1.4) | 111(1.9) | 9.477 | 0.002 | 11 054(18.3) | 2 238(21.6) | 63.723 | <0.001 |
| 饮酒[例(%)] | 7 268(32.6) | 1 549(34.8) | 8.324 | 0.004 | 1 307(3.4) | 166(2.8) | 6.061 | 0.014 | 8 575(14.2) | 1 715(16.6) | 39.915 | <0.001 |
| 年龄[M(QR),岁] | 54.0(10.0) | 56.0(10.0) | 12.403a | <0.001 | 53.0(8.0) | 56.0(8.0) | 31.874a | <0.001 | 54.0(9.0) | 56.0(9.0) | 32.620a | <0.001 |
| FBG[M(QR),mmol/L] | 5.70(1.14) | 6.40(2.30) | 38.514a | <0.001 | 5.60(1.20) | 6.40(2.40) | 46.012a | <0.001 | 5.60(1.20) | 6.40(2.40) | 60.344a | <0.001 |
| TG[M(QR),mmol/L] | 1.26(0.83) | 2.06(1.53) | 46.065a | <0.001 | 1.34(0.80) | 2.25(1.38) | 59.592a | <0.001 | 1.31(0.82) | 2.17(1.45) | 74.600a | <0.001 |
| TyG[M(QR)] | 8.67(0.70) | 9.29(0.81) | 55.643a | <0.001 | 8.72(0.66) | 9.34(0.72) | 71.337a | <0.001 | 8.70(0.67) | 9.32(0.76) | 90.000a | <0.001 |
| BMI[M(QR),kg/m2] | 24.30(3.73) | 26.17(4.00) | 35.242a | <0.001 | 24.29(4.14) | 25.92(4.59) | 33.903a | <0.001 | 24.29(3.97) | 26.03(4.38) | 48.446a | <0.001 |
| TC[M(QR),mmol/L] | 4.28(1.19) | 4.37(1.56) | 7.044a | <0.001 | 4.63(1.26) | 5.06(1.90) | 26.988a | <0.001 | 4.49(1.25) | 4.77(1.79) | 22.602a | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.36(0.50) | 1.10(0.41) | 41.533a | <0.001 | 1.50(0.52) | 1.33(0.52) | 30.568a | <0.001 | 1.45(0.52) | 1.23(0.51) | 51.037a | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.27(1.05) | 2.24(1.29) | 1.053a | 0.293 | 2.46(1.09) | 2.66(1.61) | 17.042a | <0.001 | 2.39(1.09) | 2.47(1.49) | 12.104a | <0.001 |
| 肥胖类型[例(%)] | 1 190.460 | <0.001 | 1 129.644 | <0.001 | 2 249.081 | <0.001 | ||||||
| 非肥胖 | 9 322(41.8) | 855(19.2) | 15 426(40.4) | 1 308(22.1) | 24 748(40.9) | 2 163(20.9) | ||||||
| 外周型肥胖 | 5 735(25.7) | 1 033(23.2) | 7 898(20.7) | 1 018(17.2) | 13 633(22.6) | 2 051(19.8) | ||||||
| 中心型肥胖 | 664(3.0) | 142(3.2) | 1 892(5.0) | 307(5.2) | 2 556(4.2) | 449(4.3) | ||||||
| 复合型肥胖 | 6 560(29.4) | 2 415(54.3) | 12 954(33.9) | 3 283(55.5) | 19 514(32.3) | 5 698(55.0) | ||||||
| 项目 | 非肥胖亚组(n=26 911) | 外周型肥亚组(n=15 684) | 中心性肥胖亚组(n=3 005) | 复合型肥胖亚组(n=25 212) | χ2(Z)值 | P值 |
|---|---|---|---|---|---|---|
| 在婚[例(%)] | 25 003(92.9) | 14 659(93.5) | 2 757(91.7)b | 23 328(92.5)b | 18.524 | <0.001 |
| 高中及以上学历[例(%)] | 3 339(12.4) | 1 913(12.2) | 296(9.9)ab | 2 410(9.6)ab | 128.424 | <0.001 |
| 农民[例(%)] | 16 096(59.8) | 9 283(59.2) | 1 943(64.7)ab | 16 147(64.0)ab | 148.880 | <0.001 |
| 吸烟[例(%)] | 5 378(20.0) | 3 088(19.7) | 418(13.9)ab | 4 408(17.5)abc | 108.618 | <0.001 |
| 饮酒[例(%)] | 3 709(13.8) | 2 406(15.3)a | 342(11.4)ab | 3 833(15.2)ac | 53.592 | <0.001 |
| 高血压[例(%)] | 4 660(17.3) | 3 985(25.4)a | 773(25.7)a | 9 669(38.4)abc | 2 954.106 | <0.001 |
| 糖尿病[例(%)] | 1 434(5.3) | 1 008(6.4)a | 278(9.3)ab | 2 817(11.2)abc | 675.805 | <0.001 |
| 冠心病[例(%)] | 109(0.4) | 88(0.6) | 15(0.5) | 198(0.8)ab | 33.215 | <0.001 |
| 脑卒中[例(%)] | 511(1.9) | 382(2.4)a | 73(2.4) | 793(3.1)ab | 83.748 | <0.001 |
| 血脂异常[例(%)] | 5 858(28.1) | 4 635(22.2)a | 958(4.6)a | 9 423(45.1)abc | 1 534.222 | <0.001 |
| 年龄[M(QR),岁] | 54.0(9.0) | 53.0(10.0)a | 55.0(10.0)ab | 54.0(9.0)abc | 290.407d | <0.001 |
| TG[M(QR),mmol/L] | 1.22(0.78) | 1.40(0.93)a | 1.38(0.97)a | 1.58(1.05)abc | 3 123.340d | <0.001 |
| TyG指数 | 8.62(0.68) | 8.77(0.72)a | 8.78(0.75)a | 8.94(0.75)abc | 4 281.164d | <0.001 |
| BMI[M(QR),kg/m2] | 22.19(2.13) | 25.21(2.70)a | 23.11(1.22)ab | 27.36(3.36)abc | 55 356.957d | <0.001 |
| TC[M(QR),mmol/L] | 4.47(1.29) | 4.52(1.29)a | 4.56(1.33)a | 4.58(1.36)ab | 144.250d | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.53(0.58) | 1.40(0.51)a | 1.42(0.53)a | 1.33(0.46)abc | 3 116.014d | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.33(1.10) | 2.42(1.12)a | 2.43(1.19)a | 2.44(1.16)ab | 214.088d | <0.001 |
| 性别[例(%)] | 397.257 | <0.001 | ||||
| 男 | 10 177(37.8) | 6 768(43.2)a | 806(26.8)ab | 8 975(35.6)abc | ||
| 女 | 16 734(62.2) | 8 916(56.8)a | 2 199(73.2)ab | 16 237(64.4)abc | ||
| CMD患病种数[例(%)] | 4 262.895 | <0.001 | ||||
| 0种 | 16 811(62.5) | 7 967(50.8)a | 1 435(47.8)ab | 9 143(36.3)abc | ||
| 1种 | 7 937(29.5) | 5 666(36.1)a | 1 121(37.3)a | 10 371(41.1)abc | ||
| 2种 | 1 875(7.0) | 1 740(11.1)a | 379(12.6)a | 4 635(18.4)abc | ||
| 3种 | 268(1.0) | 294(1.9)a | 63(2.1)a | 995(3.9)abc | ||
| 4种 | 19(0.1) | 15(0.1) | 6(0.2) | 66(0.3)ab | ||
| 5种 | 1(0.0) | 2(0.0) | 1(0.0) | 2(0.0) |
Table 2 Comparison of general information and CMM prevalence among middle aged residents with different obesity types in Anhui Province
| 项目 | 非肥胖亚组(n=26 911) | 外周型肥亚组(n=15 684) | 中心性肥胖亚组(n=3 005) | 复合型肥胖亚组(n=25 212) | χ2(Z)值 | P值 |
|---|---|---|---|---|---|---|
| 在婚[例(%)] | 25 003(92.9) | 14 659(93.5) | 2 757(91.7)b | 23 328(92.5)b | 18.524 | <0.001 |
| 高中及以上学历[例(%)] | 3 339(12.4) | 1 913(12.2) | 296(9.9)ab | 2 410(9.6)ab | 128.424 | <0.001 |
| 农民[例(%)] | 16 096(59.8) | 9 283(59.2) | 1 943(64.7)ab | 16 147(64.0)ab | 148.880 | <0.001 |
| 吸烟[例(%)] | 5 378(20.0) | 3 088(19.7) | 418(13.9)ab | 4 408(17.5)abc | 108.618 | <0.001 |
| 饮酒[例(%)] | 3 709(13.8) | 2 406(15.3)a | 342(11.4)ab | 3 833(15.2)ac | 53.592 | <0.001 |
| 高血压[例(%)] | 4 660(17.3) | 3 985(25.4)a | 773(25.7)a | 9 669(38.4)abc | 2 954.106 | <0.001 |
| 糖尿病[例(%)] | 1 434(5.3) | 1 008(6.4)a | 278(9.3)ab | 2 817(11.2)abc | 675.805 | <0.001 |
| 冠心病[例(%)] | 109(0.4) | 88(0.6) | 15(0.5) | 198(0.8)ab | 33.215 | <0.001 |
| 脑卒中[例(%)] | 511(1.9) | 382(2.4)a | 73(2.4) | 793(3.1)ab | 83.748 | <0.001 |
| 血脂异常[例(%)] | 5 858(28.1) | 4 635(22.2)a | 958(4.6)a | 9 423(45.1)abc | 1 534.222 | <0.001 |
| 年龄[M(QR),岁] | 54.0(9.0) | 53.0(10.0)a | 55.0(10.0)ab | 54.0(9.0)abc | 290.407d | <0.001 |
| TG[M(QR),mmol/L] | 1.22(0.78) | 1.40(0.93)a | 1.38(0.97)a | 1.58(1.05)abc | 3 123.340d | <0.001 |
| TyG指数 | 8.62(0.68) | 8.77(0.72)a | 8.78(0.75)a | 8.94(0.75)abc | 4 281.164d | <0.001 |
| BMI[M(QR),kg/m2] | 22.19(2.13) | 25.21(2.70)a | 23.11(1.22)ab | 27.36(3.36)abc | 55 356.957d | <0.001 |
| TC[M(QR),mmol/L] | 4.47(1.29) | 4.52(1.29)a | 4.56(1.33)a | 4.58(1.36)ab | 144.250d | <0.001 |
| HDL-C[M(QR),mmol/L] | 1.53(0.58) | 1.40(0.51)a | 1.42(0.53)a | 1.33(0.46)abc | 3 116.014d | <0.001 |
| LDL-C[M(QR),mmol/L] | 2.33(1.10) | 2.42(1.12)a | 2.43(1.19)a | 2.44(1.16)ab | 214.088d | <0.001 |
| 性别[例(%)] | 397.257 | <0.001 | ||||
| 男 | 10 177(37.8) | 6 768(43.2)a | 806(26.8)ab | 8 975(35.6)abc | ||
| 女 | 16 734(62.2) | 8 916(56.8)a | 2 199(73.2)ab | 16 237(64.4)abc | ||
| CMD患病种数[例(%)] | 4 262.895 | <0.001 | ||||
| 0种 | 16 811(62.5) | 7 967(50.8)a | 1 435(47.8)ab | 9 143(36.3)abc | ||
| 1种 | 7 937(29.5) | 5 666(36.1)a | 1 121(37.3)a | 10 371(41.1)abc | ||
| 2种 | 1 875(7.0) | 1 740(11.1)a | 379(12.6)a | 4 635(18.4)abc | ||
| 3种 | 268(1.0) | 294(1.9)a | 63(2.1)a | 995(3.9)abc | ||
| 4种 | 19(0.1) | 15(0.1) | 6(0.2) | 66(0.3)ab | ||
| 5种 | 1(0.0) | 2(0.0) | 1(0.0) | 2(0.0) |
| 变量 | 赋值 | 变量 | 赋值 |
|---|---|---|---|
| 年龄(岁) | 连续变量 | 高血压合并糖尿病 | 否=1,是=2 |
| 性别 | 男性=1,女性=2 | 高血压合并血脂异常 | 否=1,是=2 |
| 在婚 | 否=0,是=1 | 糖尿病合并血脂异常 | 否=1,是=2 |
| 高中及以上学历 | 否=0,是=1 | 未患CMD | 否=0,是=1 |
| 农民 | 否=0,是=1 | 患有1种CMD | 否=0,是=1 |
| 吸烟 | 否=0,是=1 | 患有2种CMD | 否=0,是=1 |
| 饮酒 | 否=0,是=1 | 患有3种CMD | 否=0,是=1 |
| 高血压 | 否=0,是=1 | 肥胖类型 | 非肥胖=1,外周型肥胖=2,中心型肥胖=3,复合型肥胖=4 |
| 糖尿病 | 否=0,是=1 | CMM | 否=1,是=2 |
| 血脂异常 | 否=0,是=1 |
Table 3 Logistic regression analysis identifying influencing factors for the risk of CMM in residents with different types of obesity
| 变量 | 赋值 | 变量 | 赋值 |
|---|---|---|---|
| 年龄(岁) | 连续变量 | 高血压合并糖尿病 | 否=1,是=2 |
| 性别 | 男性=1,女性=2 | 高血压合并血脂异常 | 否=1,是=2 |
| 在婚 | 否=0,是=1 | 糖尿病合并血脂异常 | 否=1,是=2 |
| 高中及以上学历 | 否=0,是=1 | 未患CMD | 否=0,是=1 |
| 农民 | 否=0,是=1 | 患有1种CMD | 否=0,是=1 |
| 吸烟 | 否=0,是=1 | 患有2种CMD | 否=0,是=1 |
| 饮酒 | 否=0,是=1 | 患有3种CMD | 否=0,是=1 |
| 高血压 | 否=0,是=1 | 肥胖类型 | 非肥胖=1,外周型肥胖=2,中心型肥胖=3,复合型肥胖=4 |
| 糖尿病 | 否=0,是=1 | CMM | 否=1,是=2 |
| 血脂异常 | 否=0,是=1 |
| 不同CMD的情况 | 分类 | 模型1 | 模型2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | P值 | β | SE | Wald χ2值 | 0R(95%CI) | P值 | ||
| 高血压(以非肥胖亚组为参照) | 外周型肥胖 | 0.486 | 0.024 | 396.995 | 1.626(1.550~1.706) | <0.001 | 0.528 | 0.025 | 451.378 | 1.696(1.615~1.781) | <0.001 |
| 中心型肥胖 | 0.503 | 0.045 | 126.426 | 1.654(1.515~1.805) | <0.001 | 0.453 | 0.046 | 99.098 | 1.573(1.439~1.720) | <0.001 | |
| 复合型肥胖 | 1.089 | 0.021 | 2 773.815 | 2.970(2.852~3.093) | <0.001 | 1.118 | 0.021 | 2 806.815 | 3.059(2.935~3.189) | <0.001 | |
| 糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.199 | 0.042 | 22.054 | 1.220(1.123~1.326) | <0.001 | 0.227 | 0.043 | 28.487 | 1.255(1.155~1.364) | <0.001 |
| 中心型肥胖 | 0.594 | 0.069 | 75.058 | 1.811(1.583~2.072) | <0.001 | 0.548 | 0.069 | 63.118 | 1.730(1.511~1.980) | <0.001 | |
| 复合型肥胖 | 0.804 | 0.034 | 569.110 | 2.235(2.092~2.387) | <0.001 | 0.815 | 0.034 | 577.655 | 2.259(2.114~2.415) | <0.001 | |
| 血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.411 | 0.023 | 321.350 | 1.508(1.441~1.577) | <0.001 | 0.418 | 0.023 | 330.041 | 1.519(1.452~1.589) | <0.001 |
| 中心型肥胖 | 0.520 | 0.042 | 154.436 | 1.682(1.550~1.826) | <0.001 | 0.548 | 0.042 | 169.839 | 1.730(1.593~1.879) | <0.001 | |
| 复合型肥胖 | 0.763 | 0.020 | 1 502.029 | 2.145(2.064~2.229) | <0.001 | 0.794 | 0.020 | 1 602.346 | 2.212(2.128~2.300) | <0.001 | |
| 高血压合并糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.498 | 0.063 | 61.581 | 1.645(1.453~1.862) | <0.001 | 0.534 | 0.064 | 70.366 | 1.705(1.505~1.932) | <0.001 |
| 中心型肥胖 | 0.883 | 0.098 | 81.825 | 2.419(1.998~2.930) | <0.001 | 0.820 | 0.098 | 69.786 | 2.271(1.873~2.753) | <0.001 | |
| 复合型肥胖 | 1.280 | 0.051 | 634.740 | 3.595(3.254~3.971) | <0.001 | 1.293 | 0.051 | 642.058 | 3.645(3.298~4.029) | <0.001 | |
| 高血压合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.658 | 0.041 | 263.288 | 1.932(1.784~2.092) | <0.001 | 0.679 | 0.041 | 278.167 | 1.973(1.821~2.137) | <0.001 |
| 中心型肥胖 | 0.641 | 0.072 | 80.270 | 1.899(1.650~2.185) | <0.001 | 0.625 | 0.072 | 75.538 | 1.868(1.623~2.151) | <0.001 | |
| 复合型肥胖 | 1.310 | 0.034 | 1 501.144 | 3.705(3.468~3.959) | <0.001 | 1.331 | .034 | 1 532.780 | 3.784(3.540~4.045) | <0.001 | |
| 糖尿病合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.472 | 0.071 | 44.672 | 1.602(1.395~1.840) | <0.001 | 0.495 | 0.071 | 49.060 | 1.640(1.428~1.884) | <0.001 |
| 中心型肥胖 | 0.885 | 0.108 | 67.695 | 2.423(1.963~2.992) | <0.001 | 0.869 | 0.108 | 64.743 | 2.383(1.929~2.945) | <0.001 | |
| 复合型肥胖 | 1.144 | 0.057 | 403.614 | 3.140(2.809~3.511) | <0.001 | 1.167 | 0.057 | 417.047 | 3.211(2.871~3.592) | <0.001 | |
| 未患CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.478 | 0.020 | 551.544 | 1.612(1.549~1.678) | <0.001 | 0.510 | 0.021 | 611.322 | 1.665(1.599~1.734) | <0.001 |
| 中心型肥胖 | 0.599 | 0.039 | 240.763 | 1.821(1.688~1.964) | <0.001 | 0.581 | 0.039 | 220.593 | 1.788(1.656~1.930) | <0.001 | |
| 复合型肥胖 | 1.073 | 0.018 | 3 490.432 | 2.925(2.823~3.031) | <0.001 | 1.105 | 0.018 | 3 585.453 | 3.020(2.913~3.131) | <0.001 | |
| 患1种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.302 | 0.021 | 199.960 | 1.352(1.297~1.410) | <0.001 | 0.310 | 0.021 | 210.256 | 1.363(1.308~1.422) | <0.001 |
| 中心型肥胖 | 0.352 | 0.040 | 77.523 | 1.422(1.315~1.538) | <0.001 | 0.345 | 0.040 | 73.765 | 1.412(1.305~1.527) | <0.001 | |
| 复合型肥胖 | 0.513 | 0.019 | 768.839 | 1.671(1.611~1.732) | <0.001 | 0.520 | 0.019 | 782.318 | 1.681(1.621~1.744) | <0.001 | |
| 患2种CMD(以非肥胖组为参照) | 外周型肥胖 | 0.516 | 0.035 | 213.702 | 1.666(1.556~1.784) | <0.001 | 0.537 | 0.035 | 233.923 | 1.721(1.598~1.834) | <0.001 |
| 中心型肥胖 | 0.656 | 0.060 | 119.793 | 1.927(1.714~2.167) | <0.001 | 0.626 | 0.060 | 107.499 | 1.870(1.661~2.105) | <0.001 | |
| 复合型肥胖 | 1.101 | 0.029 | 1 447.633 | 3.008(2.842~3.183) | <0.001 | 1.121 | 0.029 | 1 476.690 | 3.068(2.897~3.248) | <0.001 | |
| 患3种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.641 | 0.085 | 56.860 | 1.899(1.608~2.244) | <0.001 | 0.675 | 0.085 | 62.749 | 1.964(1.662~2.321) | <0.001 |
| 中心型肥胖 | 0.756 | 0.141 | 28.571 | 2.129(1.614~2.808) | <0.001 | 0.704 | 0.142 | 24.649 | 2.021(1.531~2.669) | <0.001 | |
| 复合型肥胖 | 1.407 | 0.069 | 411.258 | 4.085(3.565~4.680) | <0.001 | 1.425 | 0.070 | 419.137 | 4.158(3.628~4.766) | <0.001 | |
| 是否为CMM(以非肥胖亚组为参照) | 外周型肥胖 | 0.543 | 0.033 | 277.290 | 1.721(1.615~1.835) | <0.001 | 0.577 | 0.033 | 307.307 | 1.780(1.669~1.899) | <0.001 |
| 中心型肥胖 | 0.698 | 0.056 | 156.131 | 2.010(1.801~2.242) | <0.001 | 0.665 | 0.056 | 138.890 | 1.944(1.741~2.171) | <0.001 | |
| 复合型肥胖 | 1.206 | 0.027 | 1 994.582 | 3.341(3.169~3.522) | <0.001 | 1.236 | 0.027 | 2 047.441 | 3.441(3.262~3.630) | <0.001 | |
| TyG(以非肥胖亚组为参照) | 外周型肥胖 | 0.475 | 0.020 | 547.214 | 1.608(1.545~1.673) | <0.001 | 0.485 | 0.020 | 564.661 | 1.623(1.560~1.690) | <0.001 |
| 中心型肥胖 | 0.504 | 0.039 | 170.502 | 1.655(1.534~1.785) | <0.001 | 0.501 | 0.039 | 167.355 | 1.651(1.530~1.781) | <0.001 | |
| 复合型肥胖 | 0.978 | 0.018 | 2 932.076 | 2.659(2.566~2.754) | <0.001 | 0.996 | 0.018 | 3 002.676 | 2.708(2.613~2.806) | <0.001 | |
Figure 4 Logistic regression analysis identifying influencing factors for the risk of CMM in residents with different types of obesity
| 不同CMD的情况 | 分类 | 模型1 | 模型2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | P值 | β | SE | Wald χ2值 | 0R(95%CI) | P值 | ||
| 高血压(以非肥胖亚组为参照) | 外周型肥胖 | 0.486 | 0.024 | 396.995 | 1.626(1.550~1.706) | <0.001 | 0.528 | 0.025 | 451.378 | 1.696(1.615~1.781) | <0.001 |
| 中心型肥胖 | 0.503 | 0.045 | 126.426 | 1.654(1.515~1.805) | <0.001 | 0.453 | 0.046 | 99.098 | 1.573(1.439~1.720) | <0.001 | |
| 复合型肥胖 | 1.089 | 0.021 | 2 773.815 | 2.970(2.852~3.093) | <0.001 | 1.118 | 0.021 | 2 806.815 | 3.059(2.935~3.189) | <0.001 | |
| 糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.199 | 0.042 | 22.054 | 1.220(1.123~1.326) | <0.001 | 0.227 | 0.043 | 28.487 | 1.255(1.155~1.364) | <0.001 |
| 中心型肥胖 | 0.594 | 0.069 | 75.058 | 1.811(1.583~2.072) | <0.001 | 0.548 | 0.069 | 63.118 | 1.730(1.511~1.980) | <0.001 | |
| 复合型肥胖 | 0.804 | 0.034 | 569.110 | 2.235(2.092~2.387) | <0.001 | 0.815 | 0.034 | 577.655 | 2.259(2.114~2.415) | <0.001 | |
| 血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.411 | 0.023 | 321.350 | 1.508(1.441~1.577) | <0.001 | 0.418 | 0.023 | 330.041 | 1.519(1.452~1.589) | <0.001 |
| 中心型肥胖 | 0.520 | 0.042 | 154.436 | 1.682(1.550~1.826) | <0.001 | 0.548 | 0.042 | 169.839 | 1.730(1.593~1.879) | <0.001 | |
| 复合型肥胖 | 0.763 | 0.020 | 1 502.029 | 2.145(2.064~2.229) | <0.001 | 0.794 | 0.020 | 1 602.346 | 2.212(2.128~2.300) | <0.001 | |
| 高血压合并糖尿病(以非肥胖亚组为参照) | 外周型肥胖 | 0.498 | 0.063 | 61.581 | 1.645(1.453~1.862) | <0.001 | 0.534 | 0.064 | 70.366 | 1.705(1.505~1.932) | <0.001 |
| 中心型肥胖 | 0.883 | 0.098 | 81.825 | 2.419(1.998~2.930) | <0.001 | 0.820 | 0.098 | 69.786 | 2.271(1.873~2.753) | <0.001 | |
| 复合型肥胖 | 1.280 | 0.051 | 634.740 | 3.595(3.254~3.971) | <0.001 | 1.293 | 0.051 | 642.058 | 3.645(3.298~4.029) | <0.001 | |
| 高血压合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.658 | 0.041 | 263.288 | 1.932(1.784~2.092) | <0.001 | 0.679 | 0.041 | 278.167 | 1.973(1.821~2.137) | <0.001 |
| 中心型肥胖 | 0.641 | 0.072 | 80.270 | 1.899(1.650~2.185) | <0.001 | 0.625 | 0.072 | 75.538 | 1.868(1.623~2.151) | <0.001 | |
| 复合型肥胖 | 1.310 | 0.034 | 1 501.144 | 3.705(3.468~3.959) | <0.001 | 1.331 | .034 | 1 532.780 | 3.784(3.540~4.045) | <0.001 | |
| 糖尿病合并血脂异常(以非肥胖亚组为参照) | 外周型肥胖 | 0.472 | 0.071 | 44.672 | 1.602(1.395~1.840) | <0.001 | 0.495 | 0.071 | 49.060 | 1.640(1.428~1.884) | <0.001 |
| 中心型肥胖 | 0.885 | 0.108 | 67.695 | 2.423(1.963~2.992) | <0.001 | 0.869 | 0.108 | 64.743 | 2.383(1.929~2.945) | <0.001 | |
| 复合型肥胖 | 1.144 | 0.057 | 403.614 | 3.140(2.809~3.511) | <0.001 | 1.167 | 0.057 | 417.047 | 3.211(2.871~3.592) | <0.001 | |
| 未患CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.478 | 0.020 | 551.544 | 1.612(1.549~1.678) | <0.001 | 0.510 | 0.021 | 611.322 | 1.665(1.599~1.734) | <0.001 |
| 中心型肥胖 | 0.599 | 0.039 | 240.763 | 1.821(1.688~1.964) | <0.001 | 0.581 | 0.039 | 220.593 | 1.788(1.656~1.930) | <0.001 | |
| 复合型肥胖 | 1.073 | 0.018 | 3 490.432 | 2.925(2.823~3.031) | <0.001 | 1.105 | 0.018 | 3 585.453 | 3.020(2.913~3.131) | <0.001 | |
| 患1种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.302 | 0.021 | 199.960 | 1.352(1.297~1.410) | <0.001 | 0.310 | 0.021 | 210.256 | 1.363(1.308~1.422) | <0.001 |
| 中心型肥胖 | 0.352 | 0.040 | 77.523 | 1.422(1.315~1.538) | <0.001 | 0.345 | 0.040 | 73.765 | 1.412(1.305~1.527) | <0.001 | |
| 复合型肥胖 | 0.513 | 0.019 | 768.839 | 1.671(1.611~1.732) | <0.001 | 0.520 | 0.019 | 782.318 | 1.681(1.621~1.744) | <0.001 | |
| 患2种CMD(以非肥胖组为参照) | 外周型肥胖 | 0.516 | 0.035 | 213.702 | 1.666(1.556~1.784) | <0.001 | 0.537 | 0.035 | 233.923 | 1.721(1.598~1.834) | <0.001 |
| 中心型肥胖 | 0.656 | 0.060 | 119.793 | 1.927(1.714~2.167) | <0.001 | 0.626 | 0.060 | 107.499 | 1.870(1.661~2.105) | <0.001 | |
| 复合型肥胖 | 1.101 | 0.029 | 1 447.633 | 3.008(2.842~3.183) | <0.001 | 1.121 | 0.029 | 1 476.690 | 3.068(2.897~3.248) | <0.001 | |
| 患3种CMD(以非肥胖亚组为参照) | 外周型肥胖 | 0.641 | 0.085 | 56.860 | 1.899(1.608~2.244) | <0.001 | 0.675 | 0.085 | 62.749 | 1.964(1.662~2.321) | <0.001 |
| 中心型肥胖 | 0.756 | 0.141 | 28.571 | 2.129(1.614~2.808) | <0.001 | 0.704 | 0.142 | 24.649 | 2.021(1.531~2.669) | <0.001 | |
| 复合型肥胖 | 1.407 | 0.069 | 411.258 | 4.085(3.565~4.680) | <0.001 | 1.425 | 0.070 | 419.137 | 4.158(3.628~4.766) | <0.001 | |
| 是否为CMM(以非肥胖亚组为参照) | 外周型肥胖 | 0.543 | 0.033 | 277.290 | 1.721(1.615~1.835) | <0.001 | 0.577 | 0.033 | 307.307 | 1.780(1.669~1.899) | <0.001 |
| 中心型肥胖 | 0.698 | 0.056 | 156.131 | 2.010(1.801~2.242) | <0.001 | 0.665 | 0.056 | 138.890 | 1.944(1.741~2.171) | <0.001 | |
| 复合型肥胖 | 1.206 | 0.027 | 1 994.582 | 3.341(3.169~3.522) | <0.001 | 1.236 | 0.027 | 2 047.441 | 3.441(3.262~3.630) | <0.001 | |
| TyG(以非肥胖亚组为参照) | 外周型肥胖 | 0.475 | 0.020 | 547.214 | 1.608(1.545~1.673) | <0.001 | 0.485 | 0.020 | 564.661 | 1.623(1.560~1.690) | <0.001 |
| 中心型肥胖 | 0.504 | 0.039 | 170.502 | 1.655(1.534~1.785) | <0.001 | 0.501 | 0.039 | 167.355 | 1.651(1.530~1.781) | <0.001 | |
| 复合型肥胖 | 0.978 | 0.018 | 2 932.076 | 2.659(2.566~2.754) | <0.001 | 0.996 | 0.018 | 3 002.676 | 2.708(2.613~2.806) | <0.001 | |
| 项目 | 男性 | 女性 | Z值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | β | SE | Wald χ2值 | 0R(95%CI) | ||||
| 模型1 | 外周型肥胖 | 0.697 | 0.050 | 197.506 | 2.008(1.822~2.213)a | 0.454 | 0.044 | 104.134 | 1.574(1.443~1.717)a | 3.660 | <0.001 |
| 中心性肥胖 | 0.825 | 0.100 | 68.165 | 2.281(1.875~2.774)a | 0.546 | 0.069 | 63.158 | 1.727(1.509~1.976)a | 2.293 | 0.022 | |
| 复合型肥胖 | 1.420 | 0.043 | 1 067.342 | 4.137(3.799~4.504)a | 1.070 | 0.035 | 917.026 | 2.916(2.721~3.126)a | 6.243 | <0.001 | |
| 模型2 | 外周型肥胖 | 0.392 | 0.053 | 55.806 | 1.480(1.336~1.641)a | 0.293 | 0.047 | 38.869 | 1.340(1.222~1.469)a | 1.411 | 0.158 |
| 中心性肥胖 | 0.553 | 0.106 | 27.021 | 1.738(1.411~2.141)a | 0.363 | 0.073 | 24.599 | 1.437(1.245~1.658)a | 1.474 | 0.146 | |
| 复合型肥胖 | 0.924 | 0.046 | 395.335 | 2.519(2.300~2.760)a | 0.789 | 0.038 | 439.985 | 2.201(2.045~2.369)a | 2.258 | 0.024 | |
Table 5 Comparison of the risk of CMM among male and female residents with different types of obesity
| 项目 | 男性 | 女性 | Z值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | 0R(95%CI) | β | SE | Wald χ2值 | 0R(95%CI) | ||||
| 模型1 | 外周型肥胖 | 0.697 | 0.050 | 197.506 | 2.008(1.822~2.213)a | 0.454 | 0.044 | 104.134 | 1.574(1.443~1.717)a | 3.660 | <0.001 |
| 中心性肥胖 | 0.825 | 0.100 | 68.165 | 2.281(1.875~2.774)a | 0.546 | 0.069 | 63.158 | 1.727(1.509~1.976)a | 2.293 | 0.022 | |
| 复合型肥胖 | 1.420 | 0.043 | 1 067.342 | 4.137(3.799~4.504)a | 1.070 | 0.035 | 917.026 | 2.916(2.721~3.126)a | 6.243 | <0.001 | |
| 模型2 | 外周型肥胖 | 0.392 | 0.053 | 55.806 | 1.480(1.336~1.641)a | 0.293 | 0.047 | 38.869 | 1.340(1.222~1.469)a | 1.411 | 0.158 |
| 中心性肥胖 | 0.553 | 0.106 | 27.021 | 1.738(1.411~2.141)a | 0.363 | 0.073 | 24.599 | 1.437(1.245~1.658)a | 1.474 | 0.146 | |
| 复合型肥胖 | 0.924 | 0.046 | 395.335 | 2.519(2.300~2.760)a | 0.789 | 0.038 | 439.985 | 2.201(2.045~2.369)a | 2.258 | 0.024 | |
| [1] |
蒋艳苹,罗玮,姚勇利,等. 西宁地区不同类型肥胖患者2型糖尿病患病情况分析[J]. 中国医药,2022,17(4):535-538. DOI:10.3969/j.issn.1006-6187.2017.03.010.
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
笃梦雪,吴楠,郎俊杰,等. 某校大学生不同肥胖类型与心血管疾病代谢指标的关系[J]. 中华疾病控制杂志,2021,25(11):1293-1296. DOI:10.16462/j.cnki.zhjbkz.2021.11.010.
|
| [6] |
陈祚,李苏宁,王馨,等. 我国中年人群高血压、超重和肥胖的发病率及其与心血管事件的关系[J]. 中华心血管病杂志,2020,48(1):47-53. DOI:10.3760/cma.j.issn.0253-3758.2020.01.005.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
张海峰,靳迪,吕宪玉,等. 北京某三甲医院体检人群不同肥胖类型与骨密度及握力的相关性分析[J]. 解放军医学院学报,2020,41(7):666-669,674. DOI:10.3969/j.issn.2095-5227.2020.07.003.
|
| [12] | |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
陈伟标,张艳,袁雪丽,等. 深圳市老年人"三高"共病现状及关联因素分析[J]. 中国慢性病预防与控制,2023,31(1):51-55. DOI:10.16386/j.cjpccd.issn.1004-6194.2023.01.012.
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
张迷磊,杨琼,陈海燕,等. 肥胖类型与壮族中老年居民心血管疾病危险因素发生及聚集情况的分析[J]. 广西医科大学学报,2023,40(9):1564-1569. DOI:10.16190/j.cnki.45-1211/r.2023.09.020.
|
| [25] |
徐肖倩,夏远,李海玲. 2015-2017年内蒙古自治区35~75岁居民中心型肥胖与心血管代谢性疾病和共病风险的关联研究[J]. 2024,39(6):776-780. DOI:10.3784/jbjc.202302060020.
|
| [26] |
傅方琳,潘姚佳,韩正,等. 不同性别老年人群身体圆度指数与体质量正常代谢异常表型的相关性研究:以三酰甘油葡萄糖乘积指数为潜在影响因素[J]. 中国全科医学,2024,27(30):3746-3752,3757.
|
| [27] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 中国循环杂志,2022,37(6):553-578. DOI:10.3969/j.issn.1000-3614.2022.06.001.
|
| [28] |
|
| [29] |
|
| [30] |
潘姚佳,王为强,易伟卓,等. 不同性别中年肥胖居民三酰甘油葡萄糖乘积指数与心血管疾病高危风险的关系研究[J]. 中国全科医学,2023,26(29):3628-3635. DOI:10.12114/j.issn.1007-9572.2022.0891. DOI:10.12114/j.issn.1007-9572.2022.0891.
|
| [31] |
|
| [32] |
姜博,方凯,韩雪玉,等. 北京市35~75岁居民心血管病高危人群特征[J]. 中华流行病学杂志,2022,43(3):366-372. DOI:10.3760/cma.j.cn112338-20210624-00493.
|
| [1] | YI Shanye, YANG Rong, LIAO Xiaoyang, ZHOU Yiheng, LIU Lidi, YANG Ziyu, BAI Jiaxin, JIA Yu, ZHANG Xin. Interpretation of the 2024 Blood Pressure Measurement and Assessment of Arterial Structure and Function: an Expert Group Position Paper [J]. Chinese General Practice, 2026, 29(32): 4690-4694. |
| [2] | WANG Zhongkai, WU Changyong, LI Menghan, LUO Yihua, ZHANG Bingqing, PENG Yunzhu. Association between Remnant Cholesterol Inflammatory Index and Risk of Cardiometabolic Multimorbidity in Middle-aged and Older Adults [J]. Chinese General Practice, 2026, 29(31): 4573-4581. |
| [3] | LI Lan, LIU Lidi, ZHANG Peng, LI Dongze, YANG Ziyu, CHENG Yonglang, LIAO Xiaoyang, WAN Zhi. Lifestyle Intervention-based Weight Management: an Analysis of Key Highlights from the Partial Update of the 2025 NICE Guideline Overweight and Obesity Management (NG246) [J]. Chinese General Practice, 2026, 29(30): 4353-4359. |
| [4] | ZHANG Han, CAI Genshen, FENG Zhengwen, ZHANG Kaiyue, LIAN Dongbo, ZHANG Hua, ZHANG Jing. Evaluating the Availability of Health Services for Obesity Comorbidities under Hierarchical Diagnosis and Treatment in Beijing: a Healthcare Institution Survey Study [J]. Chinese General Practice, 2026, 29(28): 4117-4124. |
| [5] | FU Xiaoya, YANG Fei, GU Keyi, GU Handong, WANG Weiqiang. Correlation between Relative Fat Mass Index and Decreased Glomerular Filtration Rate in Patients with Cardiometabolic Comorbidities [J]. Chinese General Practice, 2026, 29(28): 4187-4192. |
| [6] | LU Hongrun, ZHANG Rui, ZHAO Yu, LI Jiazhen, WANG Weiqiang. Association of Cardiometabolic Comorbidity with Estimated Glomerular Filtration Rate [J]. Chinese General Practice, 2026, 29(28): 4179-4186. |
| [7] | GUO Junchi, ZHANG Mingyan, QIN Guangning, XU Qiang, LU Meijuan. Preliminary Application of the Novel Biomarker TANS01 in Cardiovascular Risk Assessment among Individuals with Phlegm-dampness Constitution [J]. Chinese General Practice, 2026, 29(27): 3924-3930. |
| [8] | ZHANG Ying, TANG Yijun, LIU Lidi, JIANG Lihua, JIA Yu, YANG Rong, YANG Ziyu, LIAO Xiaoyang. Management of Cardiovascular Metabolic Risks in Obese Children and Adolescents in China: Based on the 2024 Italian Society of Pediatric Endocrinology and Diabetes Position Paper on Cardiometabolic Risk in Children and Adolescents with Obesity [J]. Chinese General Practice, 2026, 29(27): 3879-3887. |
| [9] | ZHAO Yuanyuan, LIU Pulin, DAI Juan, ZHANG Gang, ZHANG Wei, ZHANG Xiaoxia, DENG Qing, YAN Yaqiong. Association Study between Chinese Visceral Adiposity Index and Risk of All-cause and Cause-specific Mortality in the Elderly [J]. Chinese General Practice, 2026, 29(26): 3781-3787. |
| [10] | YANG Rui, LIAO Xiaoyang, HUANG Chuanying, YANG Ziyu, SHEN Can, JIA Yu, LIU Lidi, YANG Rong. Interpretation of the 2024 British and Irish Hypertension Society Position Statement: Investigation and Management of Hypertension in Young People [J]. Chinese General Practice, 2026, 29(26): 3726-3732. |
| [11] | YUAN Hangtao, HONG Yan, YUAN Peihong, LIN Bo, CUI Xiaoyun, LI Weiwei. Interpretable Machine Learning Models for Predicting the Risk of Incident Cardiometabolic Multimorbidity in Chinese Postmenopausal Women [J]. Chinese General Practice, 2026, 29(23): 3294-3306. |
| [12] | Expert Group on Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China, Professional Committee on Obesity Control in Women and Children, China Maternal and Child Health Research Association. Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China (Second Edition) [J]. Chinese General Practice, 2026, 29(23): 3233-3252. |
| [13] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [14] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [15] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||